ALINITY C LP(A) - COFEPRIS Registration 2283R2019 SSA
Access comprehensive regulatory information for ALINITY C LP(A) (ALINITY C LP(A)) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2283R2019 SSA and manufactured by ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.. The device was registered on December 13, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL ENSAYO ALINITY C LP(A) SE UTILIZA PARA LA DETERMINACIÓN CUANTITATIVA DE LIPOPROTEÍNA (A) EN SUERO O PLASMA HUMANOS EN EL ANALIZADOR ALINITY C. AGENTE DE DIAGNÓSTICO PARA USO IN VITRO. PARA USO EXCLUSIVO EN LABORATORIOS CLÍNICOS O DE GABINETES
THE ALINITY C LP(A) ASSAY IS USED FOR THE QUANTITATIVE DETERMINATION OF LIPOPROTEIN (A) IN HUMAN SERUM OR PLASMA IN THE ALINITY C ANALYZER. DIAGNOSTIC AGENT FOR IN VITRO USE. FOR USE IN CLINICAL OR CABINET LABORATORIES ONLY